Category:LBGAA: Difference between revisions

Latest revision as of 09:48, 30 January 2023

Archaeol

Archaeol is 2,3-di-O-alkyl sn-glycerol diether, i.e., two isopranyl chains (isoprane is saturated isoprene) are ether-attached to sn-2 and -3 positions of glycerol. Its stereochemical configuration is enantiomeric to bacterial/eukaryotic phosphatidyl glycerols where two fatty acids are acylated to sn-1 and -2 positions.

アーキオールとは2,3-di-O-アルキル sn-グリセロールジエーテル、すなわち 2 つのイソプラン（イソプレンが飽和したもの）がグリセロールの sn-2, -3 位にエーテル結合した構造です。　立体配置は 2 つの脂肪酸が sn-1, -2 位にアシル結合するバクテリアや真核細胞の脂質とちょうど表裏が逆になっています。

Some halophilic bacteria contain (C25,C25)- and (C25,C20)-chains, whose ratio against the standard (C20,C20)-type may differ significantly depending on species.

好塩菌の一部は (C25,C25)鎖や (C25,C20)鎖（sn-2が長い方のC25）を持っており、それらと通常の (C20,C20)型との量比は種によって大きく異なります。

Hydroxyarchaeol is present only among methanogens and is used as a biomarker for anoxic environment.

ヒドロキシアーキオールはメタン生成菌にのみみられるため、嫌気性環境であることのバイオマーカーとして使われます。

Archaeol (C20,C20)

Hydroxyarchaeol

Unsaturated archaeol

List

only (3 structures)
With
(9 structures)
With
(8 structures)
With
(5 structures)
With
(3 structures)
With
(14 structures)
With
(6 structures)
With
(9 structures)

No Sugar

ID	Polar group Gro: glycerol	Sugar group Glc: glucose Gul: gulose
LBGAAA0N01	P-N,N,N-trimethyl-aminopentanetetrol
LBGAAA0N02	P-N,N-dimethyl-aminopentanetetrol
LBGAAC0N01	P-Cho
LBGAAE0N01	P-Etn
LBGAAG0N01	P-Gro-P-Me
LBGAAG0N02	P-Gro
LBGAAG0N03	P-Gro-P-Me
LBGAAG0N04	P-Gro-cyclicphosphate
LBGAAG0N05	P-Gro-cyclicphosphate
LBGAAG0N06	P-Gro-P
LBGAAG0N07	P-Gro-P
LBGAAG0N08	P-Gro-HSO3
LBGAAG0N09	P-Gro
LBGAAP0N01	P
LBGAAS0N01	P-Ser
LBGAAX0N01	P-ArOH, P-ArOH
LBGAAX0N02	P-ArOH

One Sugar including inositol

ID	Polar group Gro: glycerol	Sugar group Glc: glucose Gul: gulose
LBGAAI1N01	P-Ino
LBGAAI1N02	P-Ino
LBGAAI1N03	P-Ino-P
LBGAAN1G01		Glcpb
LBGAAN1G02		Galpb
LBGAAN1G03		P-Glcpa
LBGAAX1X01	P-GlcNAc

Two Sugars including inositol

ID	Polar group Gro: glycerol	Sugar group Glc: glucose Gul: gulose
LBGAAI2N02	P-(Glcpa)Ino
LBGAAI2X01	P-(N-Glcpa)Ino
LBGAAN2G01		Glcpa1-2(6-Oac)Galfb
LBGAAN2G02		Glcpb1-6Glcpa
LBGAAN2G03		Glcpa1-2Galfb
LBGAAN2G04		Galfb1-6Galfb
LBGAAN2G05		Glcpb1-6Glcpb
LBGAAN2M01		Manpa1-3Galpb
LBGAAN2M02		Manpa1-2Glcpa
LBGAAN2S01		2-HSO3-Manpa1-2Glcpa
LBGAAN2S02		6-HSO3-Manpa1-2Glcpa
LBGAAN2S03		2-HSO3-Manpa1-4Glcpa
LBGAAN2S04		2,6-di-HSO3-Manpa1-2Glcpa
LBGAAN2S05		2,6-di-HSO3-Manpa1-2Glcpa
LBGAAN2S06		6-HSO3-Manpa1-2(6-ArOP-)Glcpa
LBGAAN2X01		acetyldiglycosyl

Three or more including inositol

ID	Polar group Gro: glycerol	Sugar group Glc: glucose Gul: gulose
LBGAAN3M01		Glcpb1-6Manpa1-2Glcpa
LBGAAN3M02		Galpb1-6Manpa1-2Glcpa
LBGAAN3S01		3-HSO3-Galpb1-6Manpa1-2(6-ArOP-)Glcpa
LBGAAN3S02		HSO3-Galpb1-6Manpa1-2Glcpa
LBGAAN4M01		Galpb1-6(Galfb1-3)Manpa1-2Glcpa
LBGAAN4S01		HSO3-Galpb1-6(Galfb1-3)Manpa1-2Glcpa

This category currently contains no pages or media.

@@ Line 9: / Line 9: @@
 |アーキオールとは2,3-di-O-アルキル sn-グリセロール ジエーテル、すなわち 2 つのイソプラン（イソプレンが飽和したもの）がグリセロールの ''sn''-2, -3 位にエーテル結合した構造です。　立体配置は 2 つの脂肪酸が ''sn''-1, -2 位にアシル結合するバクテリアや真核細胞の脂質とちょうど表裏が逆になっています。
 }}{{Twocolumn
-|Some halophilic bacteria contain [[LBGAAN0N03|(C25,C25)]]- and [[LBGAAN0N02|(C25,C20)]]-chains, whose ratio against the standard (C20,C20)-type may differ significantly depending on species.
+|Some halophilic bacteria contain [[LBGAAB0N03|(C25,C25)]]- and [[LBGAAB0N02|(C25,C20)]]-chains, whose ratio against the standard (C20,C20)-type may differ significantly depending on species.
 |好塩菌の一部は (C25,C25)鎖 や (C25,C20)鎖（''sn''-2が長い方のC25）を持っており、それらと通常の (C20,C20)型との量比は種によって大きく異なります。
 }}{{Twocolumn
@@ Line 18: / Line 18: @@
 |align="center"|
 '''Archaeol''' (C20,C20)
-[[File:LBGAAN0N01.png]]<br/><br/>
+[[File:LBGAAB0N01.png]]<br/><br/>
 '''Hydroxyarchaeol'''
-[[File:LBGAHN0N01.png]]<br/><br/>
+[[File:LBGAHB0N01.png]]<br/><br/>
 '''Unsaturated archaeol'''
-[[File:LBGAUN0N01.png]]<br/><br/>
+[[File:LBGAUB0N01.png]]<br/><br/>
 |}
 ==List==
-{{#if:{{#SearchTitle:LBGAAA}}|* {{Volatile:ListMol|LBGAA[AX]|aminopentanetetrol and others}} }}
+{{#def:NumB|{{#CountTitle:LBGAA[B]}}}}{{#def:NumG|{{#CountTitle:LBGAA[G]}}}}{{#def:NumSCEI|{{#CountTitle:LBGAA[SCEI]}}}}{{#def:NumAX|{{#CountTitle:LBGAA[AX]}}}}{{#def:NumN1|{{#CountTitle:LBGAA[N]1}}}}{{#def:NumN2|{{#CountTitle:LBGAA[N]2}}}}{{#def:NumN3|{{#CountTitle:LBGAA[N][3456789]}}}}{{#def:NumS|{{#CountTitle:LBGAA..S}}}}
+{{#ifeq:{{#var:NumB}}|0||* {{#volatile:ListMol| Core lipid|LBGAA[B]}} only ({{#var:NumB}} structures)}}
+{{#ifeq:{{#var:NumG}}|0||* With {{#volatile:ListMol|glycerol|LBGAA[G]}} ({{#var:NumG}} structures)}}
+{{#ifeq:{{#var:NumSCEI}}|0||* With {{#volatile:ListMol|serine, choline, ethanolamine and inositol|LBGAA[SCEI]}} ({{#var:NumSCEI}} structures) }}
+{{#ifeq:{{#var:NumAX}}|0||* With {{#volatile:ListMol|aminopentanetetrol and others|LBGAA[AX]}} ({{#var:NumAX}} structures)}}
+{{#ifeq:{{#var:NumN1}}|0||* With {{#volatile:ListMol|1 saccharide|LBGAA[N]1}} ({{#var:NumN1}} structures)}}
+{{#ifeq:{{#var:NumN2}}|0||* With {{#volatile:ListMol|2 saccharides|LBGAA[N]2}} ({{#var:NumN2}} structures)}}
+{{#ifeq:{{#var:NumN3}}|0||* With {{#volatile:ListMol|>3 saccharides|LBGAA[N][3456789]}} ({{#var:NumN3}} structures)}}
+{{#ifeq:{{#var:NumS}}|0||* With {{#volatile:ListMol|sulfate|LBGAA..S}} ({{#var:NumS}} structures)}}
+{{LBGA/GroupTable|LBGAA}}